This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TEAD2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TEAD2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~49.2 kDa | |
| Observed band | ~49 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | — | |
| Caveat | Alternative splicing isoforms | |
| Regulation | IL-2-induced | |
| Isoform | 4 isoform(s) |
Literature-validated Western blot parameters for TEAD2 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human Hela . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-ETF/TEAD2 antigen affinity purified polyclonal antibody (Catalog # A09168-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for ETF/TEAD2 at approximately 49KD. The expected band size for ETF/TEAD2 is at 49KD |
| Gel % | 10–12% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 49 kDa |
TEAD2 has a 49.2 kDa predicted mass and runs at ~49 kDa on Western blots, closely matching prediction since it lacks glycosylation, disulfide bonds, and proteolytic processing.
| Single band at ~49 kDa | Matches the unmodified 49.2 kDa predicted mass of TEAD2, consistent with no glycosylation or proteolytic processing |
| Band unchanged after glycosidase (e.g. PNGase F) treatment | TEAD2 has no annotated glycosylation sites, so its apparent mass is not glyco-dependent |
| No shift in band position between reducing and non-reducing gels | TEAD2 has no annotated disulfide bonds and does not form a covalent homodimer, so it runs as a monomer either way |
| No smaller cleaved fragment beneath the main band | TEAD2 has no signal peptide or propeptide, so there is no precursor-to-mature cleavage step to shrink the band |
| Closely spaced doublet or extra faint band near 49 kDa | TEAD2 has four annotated splice isoforms that can migrate as slightly different species around the same size |
| Band present in nuclear fraction but weak or absent in cytoplasmic fraction | TEAD2 is annotated as a nuclear protein, so it should be enriched in nuclear extracts rather than whole cytoplasm |
| Predicted molecular weight from UniProt (49.2 kDa) | Sets the baseline expectation, and matches the ~49 kDa band actually observed on Western blot |
| Absence of annotated glycosylation sites | Keeps the band close to its unmodified predicted mass rather than shifting or smearing higher |
| Absence of annotated disulfide bonds or homodimer formation | Band stays monomeric and does not double in apparent size under non-reducing conditions |
| Named splice isoforms 1, 2, 3, and 4 | Can produce additional closely spaced bands of slightly different apparent size around the main band |
| Absence of signal peptide or propeptide | No precursor-to-mature cleavage occurs, so no smaller processed fragment appears below the main band |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TEAD2 is a nuclear transcription factor, and whole-cell lysis that poorly recovers nuclear protein can under-represent it | Use a nuclear or whole-cell extraction method optimized for nuclear proteins and load sufficient total protein from a TEAD2-expressing sample |
| Multiple bands | Four annotated splice isoforms of TEAD2 can generate closely spaced species near the main band | Check whether the antibody epitope overlaps all isoforms and compare band pattern to the canonical isoform 1 size |
| Band higher than expected | Detection of a larger splice isoform rather than the canonical form | Compare the apparent size to the ~49 kDa canonical band and confirm the immunogen region is present in the detected isoform |
| Band lower than expected | Detection of a shorter splice isoform or partial degradation during nuclear lysate preparation | Add protease inhibitors during lysis and compare against the canonical ~49 kDa isoform 1 band |
| Weak or no signal | TEAD2 is a nuclear protein and inefficient nuclear lysis or low loading can under-represent it | Use a dedicated nuclear extraction buffer, increase protein loading, and extend primary antibody incubation |
| Fragments below expected size | Nuclear TEAD2 can undergo proteolytic degradation during sample preparation | Prepare lysates on ice with protease inhibitors and minimize freeze-thaw cycles before loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for TEAD2, answered from its protein features.
BosterBio's TEAD2 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
One Boster antibody is available for TEAD2 western blotting, A09168-2, shown here with its own WB validation image. Data beyond this single image (citations, independent replication, negative-control comparisons) are not provided, so claims are limited to what the image shows.
Which to pick: Only one option is listed for TEAD2: A09168-2, which includes a real WB image (SDS-PAGE, 5-20% gel). Choose it by default since it is the sole catalogued anti-TEAD2 WB antibody here; confirm species/lysate match before use.